Dove — MON SOIN cocooning
Shower gel.
- Risk level
- Serious risk
- Typ
- Chemical
- Kategori
- Cosmetics
- Fara
- According to the list of ingredients the product contains 2-(4-tert- butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
- Origin
- United Kingdom
⚖️ Åtgärder ordnade av myndigheter
- ▸ (to: Other) Withdrawal of the product from market
- ▸ Measures ordered by economic operators (to: Distributor) Withdrawal of the product from market
8711600363618
What is this? This is a body-care cream called Dove MON SOIN cocooning. It is a cosmetic product sold in the Czech Republic.
What's happening? The cream contains a chemical called BMHCA that is not allowed in cosmetics. BMHCA may harm the reproductive system, harm an unborn baby, or cause skin reactions.
Does this affect me? Anyone who has used this cream may be at risk. Pregnant women and people with sensitive skin should be especially careful.
What should I do? Stop using the cream right away. Ask your pharmacist or doctor if you have any concerns or reactions.
🤖 Denna lättläst sammanfattning har genererats automatiskt från myndighetens officiella meddelande med hjälp av AI. Informationen är endast avsedd för allmän kännedom — inte som medicinsk rådgivning. För beslut om din hälsa, rådfråga alltid apotekspersonal eller läkare och läs den officiella källan som länkas nedan.
🔬 Medicinska/tekniska detaljer för yrkesverksamma
Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients the product contains 2-(4-tert- butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. · Origin: United Kingdom
All information på denna sida kommer från den officiella myndighetsnotisen. Vi översätter och sammanfattar den; vi lägger inte till eller ändrar fakta.
